Literature DB >> 27829681

Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves' ophthalmopathy.

Aleksander Kuś1, Konrad Szymański2, Beata Jurecka-Lubieniecka3, Edyta Pawlak-Adamska4, Dorota Kula3, Piotr Miśkiewicz1, Marek Bolanowski5, Rafał Płoski2, Artur Bossowski6, Jacek Daroszewski5, Barbara Jarząb3, Tomasz Bednarczuk1.   

Abstract

The role of TPO gene polymorphism in the susceptibility to Graves' disease (GD) remains unclear. However, single-nucleotide polymorphisms (SNPs) near TPO have been recently associated with serum levels of thyroid peroxidase (TPO) antibody in two independent genome-wide association studies. Moreover, we have observed a strong association between the rs11675434 SNP located near TPO and the presence of clinically evident Graves' ophthalmopathy (GO). The aim of the current study was to reevaluate and dissect this association in an extended group of 1231 well-characterized patients with GD (1043 adults and 188 children) and 1130 healthy controls from the Polish Caucasian population, considering possible gender-dependent and age-of-onset-specific effects of the studied SNP. We found that the T allele of rs11675434 was significantly more frequent in GD patients with than without GO (odds ratio (OR)=1.26, 95% confidence interval (CI)=1.05-1.51, P=0.012), which was consistent with our previous findings. Further analyses performed in subgroups of patients showed that the association with GO was significant in adult patients with age of GD onset ⩾45 years (OR=1.34, 95% CI=1.03-1.75, P=0.031), but not in children and adolescents or adult patients with earlier onset of the disease (OR=1.72, 95% CI=0.77-3.84, P=0.18 and OR=1.05, 95% CI=0.79-1.40, P=0.75, respectively). Moreover, a strong association with GO was present in males (OR=2.06, 95% CI=1.40-3.02, P=0.0002), whereas it was absent in females (OR=1.10, 95% CI=0.90-1.35, P=0.35). The results of our study further suggest that rs11675434 SNP located near TPO is associated with the development of GO, especially in males and patients with later age of GD onset.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27829681     DOI: 10.1038/jhg.2016.135

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  29 in total

1.  Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts.

Authors:  T H Brix; K O Kyvik; K Christensen; L Hegedüs
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

Review 2.  The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease.

Authors:  S M McLachlan; B Rapoport
Journal:  Endocr Rev       Date:  1992-05       Impact factor: 19.871

3.  A genome-wide association study identifies two new risk loci for Graves' disease.

Authors:  Xun Chu; Chun-Ming Pan; Shuang-Xia Zhao; Jun Liang; Guan-Qi Gao; Xiao-Mei Zhang; Guo-Yue Yuan; Chang-Gui Li; Li-Qiong Xue; Min Shen; Wei Liu; Fang Xie; Shao-Ying Yang; Hai-Feng Wang; Jing-Yi Shi; Wei-Wei Sun; Wen-Hua Du; Chun-Lin Zuo; Jin-Xiu Shi; Bing-Li Liu; Cui-Cui Guo; Ming Zhan; Zhao-Hui Gu; Xiao-Na Zhang; Fei Sun; Zhi-Quan Wang; Zhi-Yi Song; Cai-Yan Zou; Wei-Hua Sun; Ting Guo; Huang-Ming Cao; Jun-Hua Ma; Bing Han; Ping Li; He Jiang; Qiu-Hua Huang; Liming Liang; Li-Bin Liu; Gang Chen; Qing Su; Yong-De Peng; Jia-Jun Zhao; Guang Ning; Zhu Chen; Jia-Lun Chen; Sai-Juan Chen; Wei Huang; Huai-Dong Song
Journal:  Nat Genet       Date:  2011-08-14       Impact factor: 38.330

4.  The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy.

Authors:  D H Khoo; S C Ho; L L Seah; K S Fong; E S Tai; S P Chee; P H Eng; S E Aw; A C Fok
Journal:  Thyroid       Date:  1999-12       Impact factor: 6.568

5.  Congenital goitrous hypothyroidism: mutation analysis in the thyroid peroxidase gene.

Authors:  Fiorella S Belforte; Mirta B Miras; María C Olcese; Gabriela Sobrero; Graciela Testa; Liliana Muñoz; Laura Gruñeiro-Papendieck; Ana Chiesa; Rogelio González-Sarmiento; Héctor M Targovnik; Carina M Rivolta
Journal:  Clin Endocrinol (Oxf)       Date:  2012-04       Impact factor: 3.478

6.  A genome-wide association study on thyroid function and anti-thyroid peroxidase antibodies in Koreans.

Authors:  Soo Heon Kwak; Young Joo Park; Min Jin Go; Kyu Eun Lee; Su-Jin Kim; Hoon Sung Choi; Tae Hyuk Kim; Sung Hee Choi; Soo Lim; Ki Woong Kim; Do Joon Park; Sung Soo Kim; Jong-Young Lee; Kyong Soo Park; Hak C Jang; Nam H Cho
Journal:  Hum Mol Genet       Date:  2014-04-09       Impact factor: 6.150

7.  GO-QOL--disease-specific quality of life questionnaire in Graves' orbitopathy.

Authors:  Nadia Sawicka-Gutaj; Tomasz Bednarczuk; Jacek Daroszewski; Joanna Waligórska-Stachura; Piotr Miśkiewicz; Jerzy Sowiński; Marek Bolanowski; Marek Ruchała
Journal:  Endokrynol Pol       Date:  2015       Impact factor: 1.582

8.  Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease.

Authors:  Sandra A Rebuffat; Brigitte Nguyen; Bruno Robert; Françoise Castex; Sylvie Peraldi-Roux
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

9.  Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.

Authors:  S M McLachlan; R Bahn; B Rapoport
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

10.  Association between polymorphisms in the TSHR gene and Graves' orbitopathy.

Authors:  Beata Jurecka-Lubieniecka; Rafal Ploski; Dorota Kula; Konrad Szymanski; Tomasz Bednarczuk; Urszula Ambroziak; Kornelia Hasse-Lazar; Lidia Hyla-Klekot; Andrzej Tukiendorf; Zofia Kolosza; Barbara Jarzab
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

View more
  2 in total

Review 1.  The risk factors for Graves' ophthalmopathy.

Authors:  Jiamin Cao; Yuhe Su; Zhuokun Chen; Chen Ma; Wei Xiong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-11-17       Impact factor: 3.117

Review 2.  Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future.

Authors:  Natacha Turck; Simone Eperon; Maria De Los Angeles Gracia; Aurélie Obéric; Mehrad Hamédani
Journal:  Dis Markers       Date:  2018-03-15       Impact factor: 3.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.